Stop blaming blue light for all your problems

By editor
June 6, 2019

Blue light glasses claim to block wavelengths of light that are harmful to our eyes—but how harmful is that light to begin with? Dr. Sunir Garg says, that “There is no clinical sign or clinical evidence that people are being harmed by this,” in regards to the claims that blue light can damage our eyeballs....  read more

Alzheimer’s Disease, Dementia and the Eye

By editor
May 24, 2019

How do our eyes and brain have anything in common? Sunir Garg, MD explains that Alzheimer's disease and dementia, which are caused by damage to brain cells, both appear to have effects on the retina. Read the full article from the AAO to learn how new studies are showing how changes in the retina can detect...  read more

How did James Harden Get a Bruised Retina?

By editor
May 22, 2019

Sunir Garg, MD spoke to the American Academy of Ophthalmology to explain how James Harden, from the Houston Rockets, injured his retina and how a poke in the eye could lead to more damage. Read the full article from the AAO and check out their other article about sports-related eye injuries.

This Is What New York City Looks Like If You're Color Blind

By editor
May 1, 2019
Upload: May 1, 2019

What does color blindness look like? Forbes asked Dr. Mitchell Fineman to explain what it is, what causes it and how to treat people who do have color blindness, a condition that affects millions around the world. "Often people who are not affected by color differences do not appreciate the challenges faced by those with color...  read more

Blue-light-blocking glasses are gaining in popularity: Here's everything you should know about them

By editor
March 19, 2019
Upload: March 19, 2019

If you’ve recently gone shopping for a new pair of eyeglasses there’s a chance you may have come across some blue-light-blocking glasses, which seem to be everywhere, from online to brick-and-mortar optical stores. Blue-light block glasses are the newest trend and Dr. Sunir Garg discusses if these glasses are actually beneficial to helping reduce eye strain...  read more

Surgeons perform first gene therapy procedure aimed at stopping AMD-related blindness

By editor
February 20, 2019

Researchers have completed the first gene therapy procedure aimed at stoping age-related macular degeneration. Dr. Allen Ho commented, “What’s unique about this particular clinical trial is that they are trying gene therapy surgically delivered to the sub retinal space to try to modify the disease process of dry macular degeneration." Read the full article from...  read more

Diabetes and Eye Health - What to know about the disease’s association with vision loss

By editor
February 15, 2019

Diabetic retinopathy is the most common cause of vision loss among people with diabetes and is the most frequent cause of new cases of blindness among adults ages 20 to 74. Dr. Omesh Gupta discusses how treatments have radically improved in the recent years. Read the full article here from AARP.

Association of Intravitreal Anti–Vascular Endothelial Growth Factor Therapy With Risk of Stroke, Myocardial Infarction, and Death in Patients With Exudative Age-Related Macular Degeneration

By editor
February 8, 2019

A study recently done out of the Mayo Clinic, looked into the risk of strokes due to anti-VEGF therapy for AMD. The study has found that there is no association between the two, and the use of anti-VEGF therapy is still the best option for patients with AMD. Dr. Carl Regillo added his own comment...  read more

Statins May Prevent Diabetic Retinopathy for People with Diabetes

By editor
January 23, 2019

Dr. Sunir Garg, co-author of a study looking into how statins can help prevent diabetic retinopathy, says, “Statins may actually help patients’ eyeballs as well, not just their hearts.” Read more on this study about how people with diabetes could benefit from using statins to delay the risk of diabetic retinopathy.

One in four anti-VEGF therapy patients with DME lost to follow-up

By editor
January 18, 2019

Dr. Jason Hsu leads a study that looks into the loss of follow-up visits with patients suffering from non-proliferative diabetic retinopathy. The study has found that a quarter of patients do not return within a year of receiving an anti-VEGF injection. Read more about the study from Healio.